Details for 2018755815
Up to date per 03.04.2026
Actions
Details for 2018755815
Granted/Registered
European Patent
24.06.2020 A
23.06.2021 B1
17.08.2017
EP
17382574
C07D 401/06 20060101AFI20190222BHEP
Owner
GlaxoSmithKline Intellectual Property Development LimitedGSK Medicines Research Centre, Gunnels Wood Road Stevenage, SG1 2NYGB
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
ALEMPARTE-GALLARDO, CarlosGlaxoSmithKline Parque Tecnologico de Madrid Calle Doctor Severo Ochoa Tres Cantos 28760 MadridES
ENCINAS, LourdesGlaxoSmithKline Parque Tecnologico de Madrid Calle Doctor Severo Ochoa Tres Cantos 28760 MadridES
ESQUIVIAS PROVENCIO, JorgeGlaxoSmithKline Parque Tecnologico de Madrid Calle Doctor Severo Ochoa Tres Cantos 28760 MadridES
Information about Fees